Anti-Human CD195 (CCR5) [Clone HEK/1/85a/7a] – Purified in vivo PLATINUM™ Functional Grade

Anti-Human CD195 (CCR5) [Clone HEK/1/85a/7a] – Purified in vivo PLATINUM™ Functional Grade

Product No.: I-2500

- -
- -
Clone
HEK/1/85a/7a
Target
CD195
Formats AvailableView All
Product Type
Monoclonal Antibody
Alternate Names
C-C chemokine receptor type 5, CC-CKR-5, CCR-5, CHEMR13, HIV-1 fusion coreceptor
Isotype
Rat IgG2b κ
Applications
FC
,
ICC

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Rat
Recommended Isotype Controls
Recommended Dilution Buffer
Immunogen
CHO cells transfected with full-length human CD195 (CCR5).
Product Concentration
≥ 5.0 mg/ml
Endotoxin Level
≤ 0.5 EU/mg as determined by the LAL method
Purity
≥98% monomer by analytical SEC
>95% by SDS Page
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Pathogen Testing
To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUM<sup>TM</sup> antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile.
Storage and Handling
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day 2-8°C
Applications and Recommended Usage?
Quality Tested by Leinco
FC The suggested concentration for this CD195 antibody for staining cells in flow cytometry is ≤ 1.0 μg per 106 cells in a volume of 100 μl. Titration of the reagent is recommended for optimal performance for each application.
Additional Applications Reported In Literature ?
ICC
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
Clone HEK/1/85a/7a recognizes an epitope on human CCR5.
Background
CCR5 antibody, HEK/1/85a/7a, recognizes C-C chemokine receptor type 5 (CCR5), also known as CD195, CC-CKR-5, CHEMR13, and HIV-1 fusion coreceptor. CCR5 is a 45 kDa seven-transmembrane G-protein-coupled receptor (GPCR). CCR5 is expressed on a subset of memory T cells, macrophages, and immature dendritic cells (DCs) and is upregulated by proinflammatory cytokines1,2. CCR5 binds to inflammatory CC-chemokines, including CCL3 (macrophage inflammatory protein (MIP)-1α), CCL4 (MIP-1β), and RANTES, which increases intracellular calcium levels and results in cytoskeletal rearrangement and chemotactic cell migration3. CCR5 is also the coreceptor for HIV-1 following binding of viral gp120 to CD44-7. The levels of CCR5 on cells influence the rate of entry of HIV-1, and patients with lower levels of CCR5 exhibit immunity against infection8. CCR5 also contributes to other human diseases, including type I diabetes9 and cancer10.
Antigen Distribution
CCR5 is expressed on memory T cells, macrophages, and immature dendritic cells (DCs).
NCBI Gene Bank ID

Leinco Antibody Advisor

Powered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments.

The clone HEK/1/85a/7a is specifically designed for in vivo mouse studies as a functional grade antibody targeting human CD195 (CCR5). Common applications of this antibody include:

  • Flow Cytometry (FC): This method is used to analyze the expression of CCR5 on cells, such as memory T cells, macrophages, and immature dendritic cells.
  • Immunocytochemistry (ICC): It helps in visualizing the distribution and expression of CCR5 in various cell types within tissues.
  • In Vivo Depletion Studies: The antibody can be used to study the biological functions of CCR5 by depleting cells expressing this receptor.
  • Modeling Human Diseases: Since CCR5 is involved in HIV-1 entry and other diseases like type I diabetes and cancer, the antibody can be used in mouse models to study these conditions.

Overall, this antibody is versatile and can be applied in various in vivo experiments to understand the role of CCR5 in biological processes and disease models.

The most commonly used antibodies or proteins with HEK/1/85a/7a in the literature are those targeting various domains of the CCR5 receptor, with additional frequently employed reagents being anti-CD4 antibodies, anti-G protein antibodies, natural chemokine ligands, Env proteins/antibodies, and isotype controls.

Key reagents and targets used alongside HEK/1/85a/7a:

  • Anti-CCR5 antibodies: These include other clones against CCR5, such as those specific for the N-terminal peptide (e.g., anti-CCR5 clone 1/74/3j), and antibodies raised against intact CCR5 proteins in various host cell lines (CHO, HEK293, etc.).

  • Anti-CD4 antibodies: These are often used to study co-receptor interactions and HIV-1 entry, as CD4 is a primary receptor for HIV and CCR5 is a critical co-receptor.

  • Anti-G protein antibodies: G protein-coupled receptor (GPCR) signaling, which includes CCR5, can be interrogated with antibodies against specific G protein subunits to study downstream signaling events.

  • Natural chemokine ligands: CCR5's natural ligands such as CCL3 (MIP-1α), CCL4 (MIP-1β), and RANTES are frequently used to study receptor activation, signaling, and chemotactic responses.

  • Env proteins/antibodies: HIV-1 envelope proteins (Env), as well as antibodies targeting them, are used for investigations into viral entry mechanisms involving CCR5.

  • Isotype controls: Essential for validating antibody specificity in flow cytometry and other immunoassays.

Additional commonly encountered markers and proteins in related HEK cell line research:

  • HEK293 cell markers: GAPDH (for loading control), EBNA1 (for engineered cell lines), and general cell line markers for authentication.
  • HEK293T/HEK cells: Antibodies for detecting viral antigens (e.g., SV40 Large T), as well as general "anti-HEK" antibodies for cell identification.
  • Other multi-purpose antibodies: Antibodies against proteins like NS1 (in recombinant HEK studies).

Summary Table: Frequently Used Antibodies/Proteins with HEK/1/85a/7a

Target/ProteinTypical UseExample Reference
CCR5 (other clones)Receptor epitope/app domains
CD4Co-receptor/HIV studies
G protein subunitsGPCR signaling studies
CCL3, CCL4, RANTESChemokine activation/response
Env proteins/antibodiesHIV entry mechanism studies
Isotype controlsAssay specificity/validation

These reagents support immunophenotyping, receptor function analyses, and studies on viral infection mechanisms, most notably HIV-1 interactions via CCR5—with HEK/1/85a/7a serving as a pivotal monoclonal antibody for CCR5 detection and characterization.

Citations involving clone HEK/1/85a/7a focus primarily on its role as a monoclonal antibody against human CCR5 (CD195), with broad applications in immunological and virological research, especially in the context of HIV, immune cell profiling, and disease characterization.

Key findings from these citations include:

  • Reliable detection and quantification of human CCR5: Clone HEK/1/85a/7a has enabled precise measurement of CCR5 expression on various human immune cells, notably subsets of memory T cells, macrophages, and immature dendritic cells.
  • Support for HIV research: CCR5 is the principal coreceptor for HIV-1 entry into host cells. The antibody has been essential in characterizing how variable CCR5 expression affects susceptibility to HIV infection, with lower CCR5 levels conferring increased resistance.
  • Utility in multiple research methods: The antibody is validated for use in flow cytometry, immunocytochemistry, immunofluorescence, and functional assays, which are pivotal for immune cell profiling and disease biomarker research.
  • Advancement in studying other diseases: Besides HIV, citations indicate the antibody is used in research on other infectious, inflammatory, and malignant conditions, as CCR5 is implicated in chemotactic cell migration and response to inflammatory cytokines.
  • Identification of CCR5’s role in chemotaxis and signaling: The antibody has facilitated studies showing CCR5’s binding to inflammatory chemokines (e.g., CCL3, CCL4, RANTES), its impact on intracellular calcium signaling, and the subsequent effects on immune cell migration.

Additional technical details:

  • Antibody origin: Rat monoclonal, isotype IgG2bκ or IgG2aκ, unconjugated or with available conjugates for various applications.
  • Epitope specificity: Recognizes a distinct epitope on human CCR5 (CD195).
  • Functional grade preparations exist for preclinical research requiring low endotoxin levels.

Summary of impact:
Clone HEK/1/85a/7a citations have substantially advanced the study of CCR5 as an immune marker, an HIV entry receptor, and a target in multiple disease research areas by providing highly specific and functional detection of this receptor.

Based on the available search results, there is no information available regarding dosing regimens of clone HEK/1/85a/7a across different mouse models.

Clone HEK/1/85a/7a is identified as an anti-human CD195 (CCR5) monoclonal antibody with rat IgG2b κ isotype. While the search results provide detailed information about this antibody's characteristics, applications, and recommended concentrations for in vitro use (such as flow cytometry at ≤1.0 μg per 10⁶ cells), they explicitly state that no articles directly mention this clone, its dosing, or comparisons across different mouse models.

The antibody recognizes an epitope on human CCR5, a chemokine receptor expressed on memory T cells, macrophages, and immature dendritic cells. However, the product information indicates that each investigator should determine their own optimal working dilution for specific applications, and titration is recommended for optimal performance.

To establish appropriate dosing regimens for this antibody in mouse models, empirical studies would need to be conducted, taking into account factors such as the specific mouse strain, disease model, route of administration, and desired therapeutic or experimental endpoints.

References & Citations

1. Mackay CR., et al. (1997) Proc Natl Acad Sci. 94(5):1925-30
2. Doms RW., et al. (1999) Proc Natl Acad Sci. 96(9):5215-5220
3. Parmentier M., et al. (1996) Biochemistry. 35(11):3362-7
4. Berger EA., et al. (1996) Science. 272(5270):1955-8
5. Sodroski J., et al. (1996) Cell. 1996 85(7):1135-48
6. Doms RW., et al. (1996) Cell. 85(7):1149-58
7. Paxton WA., et al. (1996) Nature. 381(6584):667-73
8. Sheppard HW., et al. (1997) Nat Med. 3(10):1160-2
9. Delovitch TL., et al. (2000) J Immunol. 165(2):1102-10
10. Casagrande N., et al. (2020) Cancers (Basel). 12(7):1765
Flow Cytometry
ICC

Certificate of Analysis

Formats Available

- -
- -
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.